Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 29
Federal Jury Clears Merck in Ky. Man's Vioxx Lawsuit
Merck Appeals Ernst Judgment from First-Ever Vioxx Trial
Merck Reports Insurance Concerns over Vioxx Litigation
Merck Moves for Judgment in Vioxx Case as Alternative to New Trial
N.J. Judge Orders Merck to Preserve Voicemails for Vioxx Litigation
MDL Judge Consolidates Loss of Consortium, Product Liability Claims
Arthritis Drugs - Issue: 28
Vioxx Litigation and its Expanding Universe of Claimants
Arthritis Drugs - Issue: 29
Studies Find Additional Vioxx Risks, Raise Concerns about Arcoxia
